The Gross Margin of NovaBay Pharmaceuticals Inc (NBY) is 66.26%.
Gross Margin represents the percentage of revenue that exceeds the cost of goods sold. It reflects a company's efficiency in producing and selling its products.
Date | Value |
---|---|
2024-12-31 | 66.26% |
2023-12-31 | 53.61% |
2022-12-31 | 54.03% |
2021-12-31 | 70.55% |
2020-12-31 | 60.02% |
2019-12-31 | 73.64% |
2018-12-31 | 88.01% |
2017-12-31 | 84.75% |
2016-12-31 | 79.33% |
2015-12-31 | 71.23% |